Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viking Therapeutics

28.76
-0.1100-0.38%
Volume:2.73M
Turnover:77.72M
Market Cap:3.23B
PE:-24.94
High:29.01
Open:28.91
Low:27.69
Close:28.87
Loading ...

Promising Developments and Financial Stability Underpin Buy Rating for Viking Therapeutics

TIPRANKS
·
24 Apr

Viking Therapeutics Stock Dips After Q1 EPS Miss: Details

Benzinga
·
24 Apr

Viking Therapeutics Q1 Loss Widens; Shares Drop After Hours

MT Newswires Live
·
24 Apr

Earnings Flash (VKTX) Viking Therapeutics Q1 Loss of $0.41 vs. FactSet Est Loss $0.33

MT Newswires Live
·
24 Apr

Viking Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
24 Apr

Viking Therapeutics reports Q1 EPS (41c), consensus (31c)

TIPRANKS
·
24 Apr

Viking Therapeutics Q1 GAAP EPS $(0.41) Misses $(0.34) Estimate

Benzinga
·
24 Apr

Viking Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
24 Apr

Viking Therapeutics Q1 Operating Expenses USD 55.469 Million

THOMSON REUTERS
·
24 Apr

Viking Therapeutics options imply 8.5% move in share price post-earnings

TIPRANKS
·
24 Apr

Viking Therapeutics Inc : Oppenheimer Cuts Target Price to $100 From $164

THOMSON REUTERS
·
23 Apr

LLY Stock Up as Oral GLP-1 Pill Meets Goals in First Phase III Study

Zacks
·
21 Apr

Viking Therapeutics to Report Q1 Earnings: What's in the Cards?

Zacks
·
21 Apr

Wall Street Trims Ratings for Novo Nordisk Stock, as Ozempic's Competition Grows -- Barrons.com

Dow Jones
·
19 Apr

H.C. Wainwright still expects Viking to ‘differentiate’ after Lilly data

TipRanks
·
18 Apr

JPMorgan says Lilly data ‘highly favorable’ for Structure Therapeutics

TipRanks
·
18 Apr

Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know

Zacks
·
18 Apr

Viking Therapeutics Price Target Maintained With a $102.00/Share by HC Wainwright & Co.

Dow Jones
·
18 Apr

Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide

Motley Fool
·
18 Apr

Shares of Some Obesity Drug Developers Fall After Eli Lilly's Pill Leads to Weight Loss in Late-Stage Trial

THOMSON REUTERS
·
17 Apr